Literature DB >> 32591155

Spleen: Development, anatomy and reactive lymphoid proliferations.

Genevieve M Crane1, Yen-Chun Liu2, Amy Chadburn3.   

Abstract

The unique architecture of the spleen enables it to play a key role in the interactions between the circulatory, reticuloendothelial and immune systems. Response to circulating antigens in the setting of infection, autoimmune disease or other conditions may result in a range of benign lymphoid proliferations. Moreover, patients with underlying immune deficiency may also show abnormal lymphoid proliferations within the spleen. This review will highlight the histologic, immunophenotypic and clinical features of reactive lymphoid proliferations to aid in their recognition and provide a context for understanding their development in relation to normal splenic structure and function.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Acute mononucleosis; Development; Immunodeficiency; Reactive lymphoid proliferation; Spleen; Thrombocytopenia

Mesh:

Year:  2020        PMID: 32591155     DOI: 10.1053/j.semdp.2020.06.003

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  3 in total

1.  Educational Case: Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies and Potential Role of the Spleen.

Authors:  Meredith M Nichols; Genevieve M Crane
Journal:  Acad Pathol       Date:  2021-03-30

2.  Splenectomy modulates the immune response but does not prevent joint inflammation in a mouse model of RA.

Authors:  Esam Khanfar; Katalin Olasz; Erzsébet Gajdócsi; Xinkai Jia; Timea Berki; Péter Balogh; Ferenc Boldizsár
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

3.  Ameliorated Autoimmune Arthritis and Impaired B Cell Receptor-Mediated Ca2+ Influx in Nkx2-3 Knock-out Mice.

Authors:  Esam Khanfar; Katalin Olasz; Fanni Gábris; Erzsébet Gajdócsi; Bálint Botz; Tamás Kiss; Réka Kugyelka; Tímea Berki; Péter Balogh; Ferenc Boldizsár
Journal:  Int J Mol Sci       Date:  2020-08-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.